Mohamed Ahmed
Psychiatry · Baytown, TXNPI 1841338126
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,117 of the $16,429 with a category attached, or 73.8%. 32 manufacturers reported payments, led by Johnson & Johnson at 28.6% of the total. 2025 is the largest year on record at $6,237, 4.1 times the $1,515 reported in 2019. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 563 payments — averaging $29.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$5K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$1K
- Tris Pharma Inc$1K
- Takeda Pharmaceuticals U.S.A., Inc.$984
- Lundbeck LLC$863
- plus $6K from 26 others
What the payments were for
- Consulting fees$4,25026%
- Food & beverage$12,11774%
- Education$620%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 13 | $4,704 |
| Otsuka America Pharmaceutical, Inc. | 86 | $1,848 |
| AbbVie(2 entities) | 63 | $1,210 |
| Tris Pharma Inc | 32 | $1,097 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $984 |
| Lundbeck LLC | 39 | $863 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $594 |
| Neos Therapeutics, LP | 32 | $594 |
| Sunovion Pharmaceuticals Inc. | 31 | $592 |
| Corium, LLC | 42 | $548 |
| Novo Nordisk | 22 | $447 |
| Vanda Pharmaceuticals Inc. | 19 | $422 |
| Axsome Therapeutics, Inc. | 11 | $357 |
| Ironshore Pharmaceuticals Inc. | 14 | $301 |
| Supernus Pharmaceuticals, Inc. | 13 | $288 |
| Noven Therapeutics, LLC | 13 | $277 |
| Shire North American Group Inc | 14 | $264 |
| Eisai Inc. | 12 | $257 |
| Alkermes, Inc. | 7 | $165 |
| Teva Pharmaceuticals USA, Inc. | 7 | $135 |
| Adlon Therapeutics L.p. | 5 | $99 |
| Neurocrine Biosciences, Inc. | 5 | $94 |
| Tempus AI, Inc | 2 | $52 |
| Vertical Pharmaceuticals, LLC | 3 | $49 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Neuronetics, Inc. | 1 | $33 |
| Sage Therapeutics, LLC | 1 | $26 |
| Noven Pharmaceuticals, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Validus Pharmaceuticals LLC | 1 | $21 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$392
- Auvelity$109
- SPRAVATO$103
How this compares
$16,429 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 16 | $89 |
| Rosuvastatin Calcium | 12 | $55 |
| ClopidogrelClopidogrel Bisulfate | 11 | $21 |
| Omeprazole | 11 | $14 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Baytown
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
- Frank ChenHouston$941K
- Alice MaoHouston$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.